When a researcher chooses to relocate their life and family halfway across the globe, the decision is rarely driven by a single factor. For Jason Walsman, an infectious disease specialist who has called Pittsburgh home since 2020, the move to China represents a pragmatic response to a shifting scientific landscape. While the headlines focus on the high-profile tension between geopolitical powers, the reality for working scientists is far more granular: it is a question of whether the ground beneath their research will hold long enough to complete a study.
The Calculus of Scientific Migration
Walsman’s journey from the University of Pittsburgh to Duke Kunshan University was precipitated by the non-renewal of his research funding from the National Science Foundation earlier this year. His work, which focuses on interventions to prevent the extinction of frog species, requires long-term stability—a commodity that has become increasingly scarce in the current U.S. funding environment. While the Trump administration’s 2027 budget proposal signals a clear prioritization of artificial intelligence, the resulting volatility in other sectors, such as environmental and health sciences, has forced many researchers to treat their career paths as a risk-management exercise.
It is important to distinguish between the political rhetoric and the administrative reality. Jay Bhattacharya, director of the National Institutes of Health, has publicly defended the state of American research, citing the agency’s full budget utilization as proof of the U.S. remaining the premier destination for biomedical innovation. However, this perspective clashes with the lived experience of researchers like Walsman, who perceive the unpredictability of federal priorities as a fundamental barrier to their work. While officials frame the move abroad as a "foolish mistake" due to concerns over authoritarian oversight, researchers are instead weighing the "whims" of foreign governments against the immediate, tangible instability of losing domestic grants.
Tracking the Brain Drain
The exodus is not merely anecdotal. According to employment data from the White House Office of Personnel Management, more than 10,000 experts in science and related fields departed their positions at federal agencies last year. This figure serves as a sobering baseline for the current climate. Gretchen Goldman, president of the Union of Concerned Scientists, characterizes the U.S. as a "much more hostile place to do science now," suggesting that the current administrative posture is effectively ceding the country's long-standing status as a global magnet for scientific talent.
The limitation here lies in the difficulty of quantifying the exact "brain drain" beyond federal agencies. While we can track departures from government roles, the full scope of private-sector shifts or academics choosing to leave the field entirely remains elusive. Furthermore, the argument that China is simply "buying" talent ignores the systemic growth in that nation’s research investment, which, according to the Organisation for Economic Co-operation and Development, began outpacing the United States in 2024 when adjusted for purchasing power. This indicates that the shift is not just about individual career moves, but a broader, long-term trend in global resource allocation.
The Irreversible Cost of Disruption
The most significant concern raised by advocates is the potential for permanent loss of longitudinal data. Science is not a faucet that can be turned off and on without consequence; multi-decade health studies, once interrupted, often cannot be reconstituted. Goldman notes that the current disruption to the American scientific apparatus will have effects that persist for years, regardless of future policy changes.
The next reading of federal budget appropriations for the 2027 fiscal year will determine the trajectory of these research agencies. Whether Congress continues to resist proposed cuts or allows a significant contraction in health and environmental funding will provide the next measurable signal of how the U.S. intends to maintain—or forfeit—its scientific leadership in the coming decade.
